Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 522
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
for
Relapsed/Refractory KMT2A-r Acute Leukemia,
Location: Memphis TN, Atlanta GA, Cincinnati OH, Chicago IL,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT06376162
Phase1, Recruiting
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
for
High Grade Glioma, CNS Tumor
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 3
Code: NCT06528691
Phase2, Recruiting
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
for
HIV-1-infection
Location: Memphis TN, Atlanta GA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 2 - 11
Code: NCT05660980
Phase1, Phase2, Recruiting
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
for
Papillary Thyroid Cancer, Pediatric Cancer,
Location: Memphis TN, Atlanta GA, Houston TX, Philadelphia PA,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0+
Code: NCT05024929
Recruiting
Embryonal Tumor With Multilayered Rosettes
for
Embryonal Tumor With Multilayered Rosettes,
Location: Memphis TN, Birmingham AL, St Louis MO, Indianapolis IN,
Sponsor: University of California, San Francisco
Sex: All
Age: 0+
Code: NCT06861244
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy
for
Hemoglobin Disorder
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT06646640
Recruiting
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
for
Acute Lymphoblastic Leukemia, in Relapse,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT04881240
Phase1, Recruiting
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
for
Refractory Acute Myeloid Leukemia,
Location: Memphis TN, Atlanta GA, Kansas City MO, Cincinnati OH,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 30
Code: NCT06177067
Phase1, Recruiting
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
for
Survivor of Childhood Cancer, Insomnia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 20 - 50
Code: NCT07191119
Recruiting
Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
for
Health Behavior
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 26+
Code: NCT07245420
Recruiting
Screen2Prevent (S2P)
for
HIV Infections
Location: Memphis TN, Atlanta GA, Houston TX, Tampa FL,
Sponsor: Westat
Sex: All
Age: 14 - 24
Code: NCT07728123
Recruiting
Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors
for
Survivors of Childhood Cancer, Substance Use
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 15+
Code: NCT07516301
Recruiting
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
for
Gonorrhea, Chlamydia, Syphilis,
Location: Memphis TN, Chicago IL, Houston TX, Tampa FL,
Sponsor: Westat
Sex: Female
Age: 13 - 29
Code: NCT06738407
Recruiting
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
for
Pediatric Osteosarcoma
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 21
Code: NCT07428993
Phase2, Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Memphis TN, Birmingham AL, Indianapolis IN,